IFNG and colonic neoplasm: Similarly, another study developed an rNDV that expresses murine IFN-γ, but the expression of this immunomodulator did not show a significant change in the oncolytic activity against colon cancer cells (CT26 cells) in immunocompetent BALB/c mice compared with the parental virus [15].